Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression

Martin Schlegel, Monika Sharma, Emily J. Brown, Alexandra A.C. Newman, Yannick Cyr, Milessa Silva Afonso, Emma M. Corr, Graeme J. Koelwyn, Coen Van Solingen, Jonathan Guzman, Rubab Farhat, Cyrus A. Nikain, Lianne C. Shanley, Daniel Peled, Ann Marie Schmidt, Edward A. Fisher, Kathryn J. Moore

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

RATIONALE: Therapeutic efforts to decrease atherosclerotic cardiovascular disease risk have focused largely on reducing atherogenic lipoproteins, yet lipid-lowering therapies alone are insufficient to fully regress plaque burden. We postulate that arterial repair requires resolution of a maladaptive immune response and that targeting factors that hinder inflammation resolution will facilitate plaque regression. OBJECTIVE: The guidance molecule Ntn1 (netrin-1) is secreted by macrophages in atherosclerotic plaques, where it sustains inflammation by enhancing macrophage survival and blocking macrophage emigration. We tested whether silencing Ntn1 in advanced atherosclerosis could resolve arterial inflammation and regress plaques. METHODS AND RESULTS: To temporally silence Ntn1 in myeloid cells, we generated genetically modified mice in which Ntn1 could be selectively deleted in monocytes and macrophages using a tamoxifen-induced CX3CR1-driven cre recombinase (Ntn1fl/flCx3cr1creERT2+) and littermate control mice (Ntn1fl/flCx3cr1WT). Mice were fed Western diet in the setting of hepatic PCSK9 (proprotein convertase subtilisin/kexin type 9) overexpression to render them atherosclerotic and then treated with tamoxifen to initiate deletion of myeloid Ntn1 (MøΔNtn1) or not in controls (MøWT). Morphometric analyses performed 4 weeks later showed that myeloid Ntn1 silencing reduced plaque burden in the aorta (-50%) and plaque complexity in the aortic root. Monocyte-macrophage tracing experiments revealed lower monocyte recruitment, macrophage retention, and proliferation in MøΔNtn1 compared with MøWT plaques, indicating a restructuring of monocyte-macrophage dynamics in the artery wall upon Ntn1 silencing. Single-cell RNA sequencing of aortic immune cells before and after Ntn1 silencing revealed upregulation of gene pathways involved in macrophage phagocytosis and migration, including the Ccr7 chemokine receptor signaling pathway required for macrophage emigration from plaques and atherosclerosis regression. Additionally, plaques from MøΔNtn1 mice showed hallmarks of inflammation resolution, including higher levels of proresolving macrophages, IL (interleukin)-10, and efferocytosis, as compared to plaques from MøWT mice. CONCLUSION: Our data show that targeting Ntn1 in advanced atherosclerosis ameliorates atherosclerotic inflammation and promotes plaque regression.

Original languageEnglish
Pages (from-to)530-546
Number of pages17
JournalCirculation Research
Volume129
Issue number5
DOIs
StatePublished - 20 Aug 2021
Externally publishedYes

Keywords

  • Atherosclerosis
  • Cardiovascular diseases
  • Chemokines
  • Emigration
  • Myeloid cells
  • Netrin-1

Fingerprint

Dive into the research topics of 'Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression'. Together they form a unique fingerprint.

Cite this